
McKesson ideaShare 2023 recognized pharmacy technicians with a technician-focused continuing education (CE) session, roundtable, and honorary reception.
Erin Hunter is an assistant editor at Pharmacy Times®. She is a proud alumna of the University of Massachusetts. She graduated with degrees in Journalism, Art History, and Environmental Conservation.

McKesson ideaShare 2023 recognized pharmacy technicians with a technician-focused continuing education (CE) session, roundtable, and honorary reception.

The recommended addition is based on a uniform consensus that the therapy is an appropriate treatment for this difficult-to-treat disease.

During the pandemic, many community pharmacists also gained the authority to provide routine vaccinations for child populations.

The microRNA member miR-204-5p inhibits apoptosis in melanoma cells treated with dacarbazine or when overexpressed.

Increases in biological aging based on epigenetic measures could be used to inform the future of survivorship care among patients with breast cancer.

Pharmacies should start to prepare for cash flow challenges when the direct and indirect remuneration changes in 2024.

Common assumptions about each generation are often incorrect, according to an expert in generational research.

During separate panel discussions at McKesson ideaShare 2023, pharmacists discussed advocacy for pharmacy benefit manager reform and community health worker training.

McKesson also announced the rollout of the Foster & Thrive program and a new Ohio distribution center during the conference.

Pharmacists can recognize evidence of successful interventions and learn how to integrate them into their own practice.

Community health workers can address issues of health equity to enhance the services of the pharmacy and support a value-based care model.

Health Mart is offering a new basic training program with ASHP/ACPE accreditation for pharmacy technicians, along with accredited and non-accredited training.

Approximately 50% of patients with refractory or relapsed disease achieved complete response following treatment with the Janus kinase 1 (JAK1) inhibitor.

More than 4 times as many people who used the app quit smoking compared to a traditional support service.

Immunocompromised status still appears to be one of the highest independent risk factors for pneumococcal pneumonia in middle-aged and older adults.

Multivitamins were associated with increased cellular oxygen consumption and more optimal blood nutrition biomarkers.

Current social determinants of health found to have a significant impact on sleep health.

Pharmacists can help patients live a life of meaning and gratitude after cancer recovery.

Products treat ulcerative colitis, urinary tract infection, and psoriatic arthritis.

VALOR HCM is the second study to show that mavacamten can significantly reduce symptoms of obstructive hypertrophic cardiomyopathy, which includes left ventricular outflow tract.

Earlier in June, Govindan led an educational session about genomic testing at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.

Negative findings may spur choice of brand-name drugs, despite expense.

The folate alpha receptor (FRα) does have a toxicity profile, but unlike other chemotherapies, it does not severely compromise bone marrow and may improve ability to receive more therapies.

Despite having a lower cost of development than the innovator, romiplostim biosimilar has comparable efficacy and safety in patients with chronic immune thrombocytopenia.

Most tweets accurately communicated which groups of people Descovy for HIV pre-exposure prophylaxis is indicated for, although failed to mention resources about cost.

There are a multitude of benefits to smoking cessation, along with novel resources to make cessation more manageable.

Social norms appear to influence individual behavior more than personal attitudes among people living with HIV.

Brentuximab vedotin with nivolumab and standard chemotherapy agents produced a nearly 100% overall response rate in patents with early-stage classical Hodgkin lymphoma.

SB15 had a comparable safety, pharmacokinetics, and immunogenicity treatment profile to AFL for age-related macular degeneration.

The trial will also evaluate the efficacy and safety of a new form of oral pre-exposure prophylaxis for HIV.